RespiCardia System:Cardiac Concepts Inc. Developing New Implantable Device for Sleep Apnea Treatment
Cardiac Concepts Inc., a med-tech firm that’s remained largely quiet since raising $21 million in venture capital in 2008, has launched a clinical trial in Europe.
The Minnetonka-based firm has enrolled its first patient in the study, which will examine how its implantable device can help heart failure patients who suffer from sleep apnea. The company’s product, the RespiCardia System, is designed to treat central sleep apnea, where breathing is disrupted when muscles in the chest don’t work properly. The company will test its device on 40 patients.
Central sleep apnea is different from obstructive sleep apnea, a condition that causes throat muscles to contract. Twin Cities firms, including Apnex Medical Inc., are developing implantable devices to treat that condition.
Tagged with: Central Sleep Apnea • Clinical Trial • Implantable Device • Obstructive Sleep Apnea • Sleep Apnea • Sleep Apnea Device • Sleep Apnea Treatment • Treat Central Sleep Apnea
Filed under: Central Sleep Apnea • Clinical Trials • Obstructive Sleep Apnea • Respiratory Devices • Sleep Apnea • Sleep Apnea Devices • Sleep Apnea Equipments • Sleep Apnea News • Sleep Apnea Treatment
Like this post? Subscribe to my RSS feed and get loads more!
Trackbacks/Pingbacks